Month: April 2021

Readying students for careers in industry: A guided inquiry activity to prepare students for success in biotechnology and pharmaceutical industry positions

by
Readying students for careers in industry: A guided inquiry activity to prepare students for success in biotechnology and pharmaceutical industry positions

Whereas science college students are effectively ready for careers in biotechnology and pharmaceutical sciences when it comes to technical experience and significant considering, they not often have a chance to apply the due diligence required for fulfillment in business of their coursework. This contains framing their experience as options to challenges an organization could also be experiencing, an vital talent for the interview course of. As most lecturers haven’t utilized for positions in business, they could really feel ailing outfitted to assist college students apply the vital expertise of framing their experience inside firm objectives and to debate the enterprise and monetary ideas related to careers in scientific business.

Right here, we describe an academic exercise first developed by a pacesetter within the biotech/pharmaceutical business that was modified and given academic context by an instructional in a category of upper-level undergraduate and graduate college students. On this guided inquiry exercise, college students had been instructed to pick out a start-up firm of their field-ideally one to which they meant to use for a job. College students had been empowered by scaffolded hands-on workouts to analysis the corporate’s scientific focus and funds, and to border how their experience may assist firms obtain said objectives. College students compiled and delivered their analysis as an in-class presentation.

Readying students for careers in industry: A guided inquiry activity to prepare students for success in biotechnology and pharmaceutical industry positions

First Report of Cercospora Leaf Spot Attributable to Cercospora cf. flagellaris on Okra in China

Okra [Abelmoschus esculentus (L.) Moench], which belongs to the household Malvaceae, is extensively grown within the tropics, sub-tropics and hotter areas of the temperate zones for its immature seed pods that are consumed as a vegetable. In China, okra pods are consumed as not solely greens but additionally as a conventional medication to treatment dental ailments and gastric ulcers. Throughout September 2018 to June 2019, intensive spots on okra leaves had been noticed in a number of industrial fields (roughly 2.Zero hectares), with illness incidence of roughly 25%~50% within the Yanqing District (115°98’E, 40°46’N) of Beijing, China. Signs of the illness initially appeared as small pale brown spots with yellow haloes.
Because the illness progressed, some spots regularly coalesced, forming bigger irregular darkish brown lesions. The facilities of the lesions turned grayish white. A complete of 13 small fragments (Three to five mm) excised from the lesion margins had been sterilized in 1% sodium hypochlorite (NaClO) for 1 min, adopted by three washes with sterile distilled water, after which positioned on potato dextrose agar (PDA) and incubated at 25°C at midnight for five days. In whole, 21 cultures had been obtained and purified by single-spore subcultures on PDA for morphological identification.
The colonies on PDA had been whitish to grey, with cottony aerial mycelium. Conidiophores had been fasciculate, olivaceous brown, straight or geniculate, uniform in width, multiseptate, and ranged from 286/span> to 711 μm (avg. = 578 μm, n = 50). Conidia had been hyaline, barely curved or straight, needle formed, truncate on the base, and terminal on the tip, 3-17-septate, and measuring 52 to 231 μm (avg. = 182 μm, n = 50). The morphological options had been according to Cercospora cf. flagellaris Ellis & G. Martin (Groenewald et al. 2013).
Pathogenicity checks had been carried out on potted okra crops cv. ‘Jiayuan’. Twenty 4 wholesome okra crops on the true leaf stage had been sprayed with conidial suspensions (1 × 106 conidia/mL), incubated at a glass cupboard maintained at 25°C and 90% relative humidity (RH). To every leaf roughly 10 mL of conidial suspension was utilized. Crops sprayed with water had been used as controls. Seven days later, darkish brown spot, which had been similar to these noticed within the fields, had been noticed on inoculated leaves, whereas the management crops remained wholesome. C. cf. flagellaris was reisolated from symptomatic leaves, confirming Koch’s Postulates. Genomic DNA was extracted from fungal mycelium utilizing the Plant Genomic DNA Package (Tiangen Biotech Co. Ltd., Beijing, China).
The nuclear ribosomal inside transcribed spacer area (ITS), and parts of the actin (ACT), histone H3 (HIS3), and translation elongation issue 1-α (TEF1) genes had been amplified utilizing primers ITS1/ITS4 (Groenewald et al. 2013), ACT-512F/ACT-783R (Carbone & Kohn 1999), CYLH3F/CYLH3R (Crous et al. 2006), and EF1-728F/EF1-986R (Carbone & Kohn 1999). The ensuing 542 bp ITS, 226 bp ACT, 410 bp HIS3 and 306 bp TEF1 sequences of isolate QK14091813 had been deposited in GeneBank (Accession nos. MT949700, MT949701, MT949702 and MT949703, respectively).
The ITS, ACT, HIS3 and TEF1 sequences shared 99.42% to 100% identities to beforehand revealed sequences of C. cf. flagellaris (Accession nos. MN633275 for ITS, MF680960 for ACT, MK991295 for HIS3, and MK991292.1 for TEF1, respectively). Multi-locus phylogenetic analyses (ITS, ACT, HIS3, and TEF1) had been carried out by neighbor-joining methodology utilizing MEGA 7.0. The ensuing bushes confirmed that C. cf. flagellaris isolate QK14091813 (this examine) nested throughout the clade that features different isolates of C. cf. flagellaris with a 99% confidence stage. To our information, that is the primary report of C. cf. flagellaris inflicting leaf spot on okra (Farr and Rossman 2020). The pathogen has a worldwide distribution and an unusually broad host vary, which will be of nice significance, and the plant safety coverage of precedence to prevention and synthetical prevention ought to be adopted.

BMP71 soft case - EACH
LAB6028 EACH
EUR 108.69

4" Soft Rubber Brayer
M-CTP-BRY1 12 Unit
EUR 24
Description: 4" Soft Rubber Brayer

Soft Tissue Tissue Slide
MBS154324-10um 10um
EUR 210

Soft Tissue Tissue Slide
MBS154324-4um 4um
EUR 195

Soft Tissue Tissue Slide
MBS154324-5x10um 5x10um
EUR 920

Paraffin Wax Pellets (Soft)
MB267-2KG 1 unit
EUR 74
Description: Paraffin Wax Pellets (Soft)

Paraffin Wax Pellets (Soft)
MB267-500G 1 unit
EUR 21.17
Description: Paraffin Wax Pellets (Soft)

Collagel Hydrogel Soft+-Rat
CGH322 20ml
EUR 340.8

Collagel Hydrogel Soft+-Rat
MBS555785-20mL 20mL
EUR 300

Collagel Hydrogel Soft+-Rat
MBS555785-5x20mL 5x20mL
EUR 1195

Collagel Hydrogel Soft-Rat
CGH321 20ml
EUR 325.2

Collagel Hydrogel Soft+-Human
CGHH322 20ml
EUR 763.2

Collagel Hydrogel Soft-Rat
MBS555784-20mL 20mL
EUR 285

Collagel Hydrogel Soft-Rat
MBS555784-5x20mL 5x20mL
EUR 1130

Collagel Hydrogel Soft+-Human
MBS555791-20mL 20mL
EUR 625

Collagel Hydrogel Soft+-Human
MBS555791-5x20mL 5x20mL
EUR 2670

Collagel Hydrogel Soft+-Bovine
CGHB322 20ml
EUR 465.6

Collagel Hydrogel Soft+-Bovine
MBS555788-20mL 20mL
EUR 390

Collagel Hydrogel Soft+-Bovine
MBS555788-5x20mL 5x20mL
EUR 1610

Collagel Hydrogel Soft-Human
CGHH321 20ml
EUR 747.6

Collagel Hydrogel Soft-Human
MBS555790-20mL 20mL
EUR 615

Collagel Hydrogel Soft-Human
MBS555790-5x20mL 5x20mL
EUR 2615

Collagel Hydrogel Soft-Bovine
CGHB321 20ml
EUR 434.4

Collagel Hydrogel Soft-Bovine
MBS555787-20mL 20mL
EUR 365

Collagel Hydrogel Soft-Bovine
MBS555787-5x20mL 5x20mL
EUR 1500

GASKET KIT FOR SOFT. - EACH
RLPF00748 EACH
EUR 318.73

Mediana A16 Soft Bag - EACH
SAF0466 EACH
EUR 158.63

Loops Red Soft 5ul - PK1000
TS30D PK1000
EUR 122.85

Paraffin Wax White Soft pure
74193 100 Gms
EUR 1.23
Description: Part A

Soft tissue tumor tissue array
BC24011b each
EUR 270
Description: Soft tissue tumor tissue array, including TNM and clinical stage, 63 cases/63 cores, replacing BC24011a

Soft tissue tumor tissue array
SF961 each
EUR 222
Description: Soft tissue tumor tissue array, including TNM and clinical stage, 48 cases/96 cores

Soft tissue sarcoma as control
SO809c each
EUR 270
Description: Soft tissue sarcoma as control, including TNM, clinical stage and pathology grade, 80 cases/80 cores (core size 1.5mm), replacing SO809b

Soft Tissue Tissue Slide (Benign)
12-303-10um 10 um
EUR 241.8

Soft Tissue Tissue Slide (Benign)
12-303-4um 4 um
EUR 216.6

Soft Tissue Tissue Slide (Benign)
MBS154245-10um 10um
EUR 210

Soft Tissue Tissue Slide (Benign)
MBS154245-4um 4um
EUR 195

Soft Tissue Tissue Slide (Benign)
MBS154245-5x10um 5x10um
EUR 920

Soft Tissue Tissue Slide (Abnormal)
12-305-10um 10 um
EUR 241.8

Soft Tissue Tissue Slide (Abnormal)
12-305-4um 4 um
EUR 216.6

Soft Tissue Tissue Slide (Abnormal)
MBS154256-10um 10um
EUR 210

Soft Tissue Tissue Slide (Abnormal)
MBS154256-4um 4um
EUR 195

Soft Tissue Tissue Slide (Abnormal)
MBS154256-5x10um 5x10um
EUR 920

Soft tissue homogenizing CK14 - PK50
HOM1044 PK50
EUR 268.65

Soft tissue cancer test tissue array
T241 each
EUR 48
Description: Soft tissue cancer test tissue array, with normal soft tissue control tissue, including TNM, clinical stage and pathology grade, 6 cases/24 cores

Loops 10ul soft white Sterile - PK1000
TS1-B PK1000
EUR 125.55

Soft tissue sarcoma test tissue array
T243a each
EUR 66
Description: Soft tissue sarcoma test tissue array,with normal soft tissue as control,TNM/Stage ( AJCC 8th edition), 6 cases/24 cores(corse size 1.5mm)

Soft tissue sarcoma test tissue array
T243 each
EUR 66
Description: Soft tissue sarcoma test tissue array, with normal soft tissue as control, including TNM and clinical stage, 2 serial sections, 6 cases/24 cores (core size 1.5mm)

Soft tissue homogenizing CK14-0.5mL - PK50
HOM1046 PK50
EUR 268.65

Soft tissue homogenizing CK14-WP - EACH
HOM1104 EACH
EUR 365.85

Soft tissue homogenizing CK14-7mL - PK50
HOM1088 PK50
EUR 360.45

Soft tissue malignant tumor tissue array
T244 each
EUR 48
Description: Soft tissue malignant tumor tissue array, including TNM and clinical stage, 6 cases/24 cores

Soft Tissue Tissue Slide (Adipose-Normal)
12-311-10um 10 um
EUR 241.8

Soft Tissue Tissue Slide (Adipose-Normal)
12-311-4um 4 um
EUR 216.6

Soft Tissue Tissue Slide (Adipose-Benign)
12-313-10um 10 um
EUR 241.8

Soft Tissue Tissue Slide (Adipose-Benign)
12-313-4um 4 um
EUR 216.6

Soft Tissue Tissue Slide (Adipose-Lipoma)
12-314-10um 10 um
EUR 241.8

Soft Tissue Tissue Slide (Adipose-Lipoma)
12-314-4um 4 um
EUR 216.6

Soft Tissue Tissue Slide (Adipose-Lipoma)
MBS154181-10um 10um
EUR 210

Soft Tissue Tissue Slide (Adipose-Lipoma)
MBS154181-4um 4um
EUR 195

Soft Tissue Tissue Slide (Adipose-Lipoma)
MBS154181-5x10um 5x10um
EUR 920

Soft Tissue Tissue Slide (Adipose-Benign)
MBS154250-10um 10um
EUR 210

Soft Tissue Tissue Slide (Adipose-Benign)
MBS154250-4um 4um
EUR 195

Soft Tissue Tissue Slide (Adipose-Benign)
MBS154250-5x10um 5x10um
EUR 920

Soft Tissue Tissue Slide (Adipose-Normal)
MBS154286-10um 10um
EUR 210

Soft Tissue Tissue Slide (Adipose-Normal)
MBS154286-4um 4um
EUR 195

Soft Tissue Tissue Slide (Adipose-Normal)
MBS154286-5x10um 5x10um
EUR 920

Tumors of soft tissue, 102 cases (1.5mm)
SFT1021 1
EUR 300
Description: Soft tissue tumor tissue array, 102 cases of benign and malignant tumors of various soft tissues.

Tumors of soft tissue, 75 cases (1.1mm)
SFT1501 1
EUR 300
Description: Soft tissue tumor tissue array, 150 cores, 75 cases of benign and malignant tumors of various soft tissues in duplicates.

Soft Tissue Tissue Slide (Adipose-Abnormal)
12-317-10um 10 um
EUR 241.8

Soft Tissue Tissue Slide (Adipose-Abnormal)
12-317-4um 4 um
EUR 216.6

Soft Tissue Tissue Slide (Adipose-Abnormal)
MBS154243-10um 10um
EUR 210

Soft Tissue Tissue Slide (Adipose-Abnormal)
MBS154243-4um 4um
EUR 195

Soft Tissue Tissue Slide (Adipose-Abnormal)
MBS154243-5x10um 5x10um
EUR 920

3D Cell Culture Gel, soft (Col-Tgel)
P720S-10 10 mL
EUR 389

3D Cell Culture Gel, soft (Col-Tgel)
P720S-2 2 mL
EUR 189

Brush Flat Soft Hair 12mm width - EACH
BRU2000 EACH
EUR 21.58

Brush Flat Soft Hair 25mm width - EACH
BRU2002 EACH
EUR 22.37

Brush Flat Soft Hair 50mm width - EACH
BRU2004 EACH
EUR 28.29

Soft Tissue Tissue Slide (Adipose-Undiagnosed)
12-310-10um 10 um
EUR 241.8

Soft Tissue Tissue Slide (Adipose-Undiagnosed)
12-310-4um 4 um
EUR 216.6

Soft Tissue Tissue Slide (Adipose-Liposarcoma)
12-316-10um 10 um
EUR 241.8

Soft Tissue Tissue Slide (Adipose-Liposarcoma)
12-316-4um 4 um
EUR 216.6

Soft Tissue Tissue Slide (Adipose-Liposarcoma)
MBS154308-10um 10um
EUR 210

Soft Tissue Tissue Slide (Adipose-Liposarcoma)
MBS154308-4um 4um
EUR 195

Soft Tissue Tissue Slide (Adipose-Liposarcoma)
MBS154308-5x10um 5x10um
EUR 920

Brush Round Soft Hair 4mm diameter - EACH
BRU2020 EACH
EUR 5.88

Brush Round Soft Hair 6mm diameter - EACH
BRU2022 EACH
EUR 5.43

Brush Round Soft Hair 8mm diameter - EACH
BRU2024 EACH
EUR 8.81

Brush Pencil Soft Hair 1mm diameter - EACH
BRU2050 EACH
EUR 7.33

Brush Pencil Soft Hair 1.5mm diameter - EACH
BRU2052 EACH
EUR 8.59

Brush Pencil Soft Hair 2.5mm diameter - EACH
BRU2054 EACH
EUR 8.68

Brush Pencil Soft Hair 3.5mm diameter - EACH
BRU2056 EACH
EUR 8.8

Brush Pencil Soft Hair 4mm diameter - EACH
BRU2058 EACH
EUR 12.24

Soft tissue tumor with normal tissue array
SO801a each
EUR 306
Description: Soft tissue tumor with normal tissue array, including TNM and clinical stage, 80 cases/80 cores, replaced by SO801b

Soft tissue tumor array with autopsy tissue
T242b each
EUR 66
Description: Soft tissue tumor array with autopsy tissue, including TNM, clinical stage, 12 cases/ 24 cores, replacing T242a

Loop Yellow Soft 1ul Bags of 20 - PK1000
TS/4-D PK1000
EUR 122.85

Protein Safe Soft tissue homogenizing CK14 - PK50
HOM1076 PK50
EUR 375.3

Soft Tissue Tissue Slide (Skeletal Muscle-Normal)
12-341-10um 10 um
EUR 241.8

Soft Tissue Tissue Slide (Skeletal Muscle-Normal)
12-341-4um 4 um
EUR 216.6

Soft Tissue Tissue Slide (Skeletal Muscle-Benign)
12-343-10um 10 um
EUR 241.8

Soft Tissue Tissue Slide (Skeletal Muscle-Benign)
12-343-4um 4 um
EUR 216.6

Soft Tissue Tissue Slide (Skeletal Muscle-Normal)
MBS154227-10um 10um
EUR 210

Soft Tissue Tissue Slide (Skeletal Muscle-Normal)
MBS154227-4um 4um
EUR 195

Soft Tissue Tissue Slide (Skeletal Muscle-Normal)
MBS154227-5x10um 5x10um
EUR 920

Soft Tissue Tissue Slide (Skeletal Muscle-Benign)
MBS154290-10um 10um
EUR 210

Soft Tissue Tissue Slide (Skeletal Muscle-Benign)
MBS154290-4um 4um
EUR 195

Soft Tissue Tissue Slide (Skeletal Muscle-Benign)
MBS154290-5x10um 5x10um
EUR 920

Human Soft Tissue Slide (Benign) (5 slides/pk)
HTS-12303 1 pk
EUR 343.2

Common diseases of soft tissue, 24 cases (2.5mm)
SFD241 1
EUR 228
Description: Soft tissue disease tissue array, 24 cases of normal, reactive and tumor conditions of various soft tissues

Common diseases of soft tissue, 24 cases (2mm)
SFD481 1
EUR 265.2
Description: Soft tissue disease tissue array, 24 cases of reactive and tumor conditions of various soft tissues in duplicates.

Soft Tissue Tissue Slide (Skeletal Muscle-malignant)
12-345-10um 10 um
EUR 241.8

Soft Tissue Tissue Slide (Skeletal Muscle-malignant)
12-345-4um 4 um
EUR 216.6

Soft Tissue Tissue Slide (Skeletal Muscle-malignant)
MBS154272-10um 10um
EUR 210

Soft Tissue Tissue Slide (Skeletal Muscle-malignant)
MBS154272-4um 4um
EUR 195

Soft Tissue Tissue Slide (Skeletal Muscle-malignant)
MBS154272-5x10um 5x10um
EUR 920

Human Soft Tissue Slide (Abnormal) (5 slides/pk)
HTS-12305 1 pk
EUR 343.2

Tumors of soft tissue, 48 cases (1.5mm), set 1
SFT961 1
EUR 300
Description: Soft tissue tumor tissue array, set 1, non-overlapping with SFT962, 96 cores, 48 cases of benign and malignant tumors of various soft tissues in duplicates.

Tumors of soft tissue, 48 cases (1.5mm), set 2
SFT962 1
EUR 300
Description: Soft tissue tumor tissue array, set 2, non-overlapping with SFT961, 96 cores, 48 cases of benign and malignant tumors of various soft tissues in duplicates.

NGF-Receptor (p75)/CD271 (Soft Tissue Tumor Marker)
MBS4380135-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

NGF-Receptor (p75)/CD271 (Soft Tissue Tumor Marker)
MBS4380135-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

NGF-Receptor (p75)/CD271 (Soft Tissue Tumor Marker)
MBS4380135-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

NGF-Receptor (p75)/CD271 (Soft Tissue Tumor Marker)
MBS4380135-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

NGF-Receptor (p75)/CD271 (Soft Tissue Tumor Marker)
MBS4380135-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

NGF-Receptor (p75)/CD271 (Soft Tissue Tumor Marker)
MBS4380467-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

NGF-Receptor (p75)/CD271 (Soft Tissue Tumor Marker)
MBS4380467-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

NGF-Receptor (p75)/CD271 (Soft Tissue Tumor Marker)
MBS4380467-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

NGF-Receptor (p75)/CD271 (Soft Tissue Tumor Marker)
MBS4380467-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

NGF-Receptor (p75)/CD271 (Soft Tissue Tumor Marker)
MBS4380467-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

NGF-Receptor (p75)/CD271 (Soft Tissue Tumor Marker)
MBS4380642-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

NGF-Receptor (p75)/CD271 (Soft Tissue Tumor Marker)
MBS4380642-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

NGF-Receptor (p75)/CD271 (Soft Tissue Tumor Marker)
MBS4380642-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

NGF-Receptor (p75)/CD271 (Soft Tissue Tumor Marker)
MBS4380642-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

NGF-Receptor (p75)/CD271 (Soft Tissue Tumor Marker)
MBS4380642-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

NGF-Receptor (p75)/CD271 (Soft Tissue Tumor Marker)
MBS4381113-002mgWithBSAAzideat02mgmL 0.02mg(WithBSA&Azideat0.2mg/mL)
EUR 230

NGF-Receptor (p75)/CD271 (Soft Tissue Tumor Marker)
MBS4381113-01mgWithBSAAzideat02mgmL 0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 405

NGF-Receptor (p75)/CD271 (Soft Tissue Tumor Marker)
MBS4381113-01mgWithoutBSAAzideat1mgmL 0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 405

NGF-Receptor (p75)/CD271 (Soft Tissue Tumor Marker)
MBS4381113-5x01mgWithBSAAzideat02mgmL 5x0.1mg(WithBSA&Azideat0.2mg/mL)
EUR 1725

NGF-Receptor (p75)/CD271 (Soft Tissue Tumor Marker)
MBS4381113-5x01mgWithoutBSAAzideat1mgmL 5x0.1mg(WithoutBSA&Azideat1mg/mL)
EUR 1725

Diversey Soft Care Fresh Handwashing Cream 800mL - PK6
SAF5344 PK6
EUR 88.13

Soft tissue tumor with adjacent normal tissue array
SO241 each
EUR 66
Description: Soft tissue tumor with adjacent normal tissue array, including TNM and clinical stage, 12 cases/24 cores

Alveolar Soft Part Sarcoma Chromosome Region, Candidate 1
PR27224 2 ug
EUR 229.2

Alveolar Soft Part Sarcoma Chromosome Region, Candidate 1
PR27224-B each
EUR 184.5

Human Soft Tissue Slide (Adipose Normal) (5 slides/pk)
HTS-12311 1 pk
EUR 343.2

Human Soft Tissue Slide (Adipose Benign) (5 slides/pk)
HTS-12313 1 pk
EUR 343.2

Human Soft Tissue Slide (Adipose Lipoma) (5 slides/pk)
HTS-12314 1 pk
EUR 343.2

Soft tissue fibrosarcoma tissue array (2013 WHO classification)
SO961 each
EUR 306
Description: Soft tissue fibrosarcoma tissue array (2013 WHO classification), including TNM and clinical stage (AJCC 7th edition), 96 cases/96 cores

Human Soft Tissue Slide (Adipose Abnormal) (5 slides/pk)
HTS-12317 1 pk
EUR 343.2

Precellys 2mL Lysing Kits - Soft tissue Starter box - PK40
HOM1060 PK40
EUR 268.65

Recombinant Human Alveolar Soft Part Sarcoma Chromosome Region
MBS556279-0002mg 0.002mg
EUR 220

Recombinant Human Alveolar Soft Part Sarcoma Chromosome Region
MBS556279-001mg 0.01mg
EUR 320

Recombinant Human Alveolar Soft Part Sarcoma Chromosome Region
MBS556279-5x001mg 5x0.01mg
EUR 1300

Human Soft Tissue Slide (Adipose Undiagnosed) (5 slides/pk)
HTS-12310 1 pk
EUR 343.2

Human Soft Tissue Slide (Adipose Liposarcoma) (5 slides/pk)
HTS-12316 1 pk
EUR 343.2

Innovative Grade US Origin Porcine Foot Sole/Soft Tissue
IGPCFSTF each
EUR 133
Description: Innovative Grade US Origin Porcine Foot Sole/Soft Tissue

Innovative Grade US Origin Porcine Foot Sole/Soft Tissue
IGPCFSTP each
EUR 210
Description: Innovative Grade US Origin Porcine Foot Sole/Soft Tissue

Innovative Grade US Origin Porcine Foot Sole/Soft Tissue
IGPCFSTS each
EUR 210
Description: Innovative Grade US Origin Porcine Foot Sole/Soft Tissue
Plasma and nasopharyngeal samples had been collected between 14 March and 11 April 2020 at hospital admission from 45 sufferers with RT-PCR confirmed COVID-19 and 20 adverse controls. SARS-CoV-2 antigen (Ag) was assessed in nasopharyngeal swabs utilizing the Coris Respi-Strip. For IgM/IgG detection, SureScreen Diagnostics and Szybio Biotech RDTs had been used along with laboratory assays (Abbott Alinity i SARS-CoV-2 IgG and Theradiag COVID-19 IgM ELISA).

Challenges of Psychiatry Drug Development and the Role of Human Pharmacology Models in Early Development-A Drug Developer’s Perspective

by
Challenges of Psychiatry Drug Development and the Role of Human Pharmacology Models in Early Development-A Drug Developer's Perspective

Psychiatric ailments have the bottom chance of success in scientific drug improvement. This presents not solely a problem to handle the unmet medical wants of sufferers, but in addition a hurdle for pharmaceutical and biotech business to proceed R&D on this illness space. Basic pharmacokinetic and pharmacodynamic rules present an understanding of the drug publicity, goal binding and pharmacological exercise on the goal website of motion for a brand new drug candidate. Collectively, these rules decide the probability of testing the mechanism of motion and enhancing the probability of candidate survival in Part 2 scientific improvement, due to this fact, they’re termed because the “three pillars of survival.” Human Part 1 pharmacokinetic and pharmacodynamic research present proof of the three pillars. Electroencephalogram (EEG) assessments and cognitive operate assessments in schizophrenia sufferers can present proof of pharmacology and be sure that a pharmacological lively routine might be examined in Part 2 proof of idea (POC) research for the remedy of cognitive impairment related to schizophrenia (CIAS).

In our cross-sectional research, we examined 347 sufferers of our Normal Observe utilizing 2019-nCoV-2-IgG/IgM antibody check [2019-nCoV2 IgG/IgM Rapid Test Cassette (Ref.: INCP-402/INCP-402B; ACRO, BIOTECH, INC.)]. We requested for 13 particular signs and four questions to analyze sufferers’ environment.  A complete of 107 of 347 sufferers had been examined constructive for antibodies (Immunoglobulin M-positive and/or Immunoglobulin G-positive). In antibody-positive group, physique aches and rhinorrhea had been seen extra usually and there have been considerably much less asymptomatic sufferers. Keep in space of danger was considerably extra frequent in antibody-positive group in addition to contact to contaminated individuals. Distribution of different signs was not considerably totally different between each teams. Most adults or kids with SARS-CoV-2 an infection offered with gentle flu-like signs.
The detection of antibodies in opposition to the novel coronavirus SARS-CoV-2 is necessary for the prognosis, retrospective evaluation of illness development, and proper analysis of the present an infection state of affairs within the inhabitants. Many of those assays have been launched by numerous producers. Sadly, the brand new FDA emergency use rules have resulted in a state of affairs the place laboratories should carry out their very own validation research. Quite a few of those labs wouldn’t have the biobank wanted to hold the research out.

Comparability of the Diagnostic Worth of Immunochromatography Kits in Corona Virus Illness 2019 Sufferers: A Potential Pilot Examine

The unfold of coronavirus 2019 (COVID-19) is a significant issue all around the world. A number of immunochromatography kits of the antibody for extreme acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have been developed, however it’s nonetheless unclear which kits have excessive diagnostic worth. This research goals to judge the accuracy fee for antibody detection of every immunochromatography equipment and reveal which equipment has a excessive diagnostic worth for antibody detection. This research was carried out between 1 August 2020 and 14 October 2020 on the Affiliation of EISEIKAI Medical and Healthcare Company Minamitama Hospital. Sufferers recognized with COVID-19 and roughly 30 days after symptom onset had been included because the constructive group. The serum SARS-CoV-2 antibodies had been analysed utilizing seven immunochromatography kits.
Twenty samples (Constructive group: 10 sufferers, Adverse group: 10 wholesome medical staff) had been included on this research. The median age of the sufferers was 44 years, and the median period from symptom onset was 30.5 days within the constructive group. The accuracy charges for IgM/IgG detection had been: 90.0%/100% in Package A; 50.0%/95.0% in Package B; 55.0%/65.0% in Package C; 60.0%/55.0% in Package D; 50.0%/80.0% in Package E; 80.0%/90.0% in Package F; and 90.0%/100% in Package G.  Our research confirmed that there’s a variation of accuracy charges between immunochromatography kits for antibodies of SARS-CoV-2. COVID-19 IgG/IgM RAPID TEST CASSETTE (Hangzhou Biotest Biotech Co., Ltd., China) and Nadal COVID-19 IgG/IgM Speedy Check (BioServUK Ltd., UK: United Kingdom) have excessive accuracy charges for each IgM and IgG detection. Proof from giant inhabitants research of immunochromatography kits is required to make clear the main points of diagnostic worth for SARS-CoV-2.
Challenges of Psychiatry Drug Development and the Role of Human Pharmacology Models in Early Development-A Drug Developer's Perspective

Analysis of three extraction-free SARS-CoV-2 RT-PCR assays: a possible various method with low technical necessities

The worldwide demand for SARS-CoV-2 RT-PCR testing resulted in a scarcity of diagnostic kits. RNA extraction step constitutes a serious bottleneck to carry out diagnostic. The goal of this research was to evaluate performances of various extraction-free SARS-CoV-2 RT-PCR assays in comparison with a reference RT-PCR assay. The panel of analysis consisted of 94 samples: 69 constructive and 25 damaging for SARS-CoV-2 by reference RT-PCR. Three extraction-free RT-PCR assays had been assessed: (i) PrimeDirect® Probe RT-qPCR Combine (Takara), (ii) PrimeScript®RT-PCR (Takara), and (iii) SARS-CoV-2 SANSURE®BIOTECH Novel Coronavirus (Sansure).

Recombinant Hydra vulgaris Hydralysin (Hln)
MBS1393758-002mgEColi 0.02mg(E-Coli)
EUR 755

Recombinant Hydra vulgaris Hydralysin (Hln)
MBS1393758-002mgYeast 0.02mg(Yeast)
EUR 915

Recombinant Hydra vulgaris Hydralysin (Hln)
MBS1393758-01mgEColi 0.1mg(E-Coli)
EUR 905

Recombinant Hydra vulgaris Hydralysin (Hln)
MBS1393758-01mgYeast 0.1mg(Yeast)
EUR 1070

Recombinant Hydra vulgaris Pedin
MBS1149522-005mgBaculovirus 0.05mg(Baculovirus)
EUR 875

Recombinant Hydra vulgaris Pedin
MBS1149522-005mgEColi 0.05mg(E-Coli)
EUR 490

Recombinant Hydra vulgaris Pedin
MBS1149522-005mgYeast 0.05mg(Yeast)
EUR 695

Recombinant Hydra vulgaris Pedin
MBS1149522-02mgEColi 0.2mg(E-Coli)
EUR 640

Recombinant Hydra vulgaris Pedin
MBS1149522-05mgEColi 0.5mg(E-Coli)
EUR 700

Recombinant Hydra vulgaris Pedibin
MBS1148200-005mgBaculovirus 0.05mg(Baculovirus)
EUR 880

Recombinant Hydra vulgaris Pedibin
MBS1148200-005mgEColi 0.05mg(E-Coli)
EUR 500

Recombinant Hydra vulgaris Pedibin
MBS1148200-005mgYeast 0.05mg(Yeast)
EUR 700

Recombinant Hydra vulgaris Pedibin
MBS1148200-02mgEColi 0.2mg(E-Coli)
EUR 655

Recombinant Hydra vulgaris Pedibin
MBS1148200-05mgEColi 0.5mg(E-Coli)
EUR 700

Recombinant Hydra vulgaris Antistasin
MBS1248250-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1120

Recombinant Hydra vulgaris Antistasin
MBS1248250-002mgEColi 0.02mg(E-Coli)
EUR 700

Recombinant Hydra vulgaris Antistasin
MBS1248250-002mgYeast 0.02mg(Yeast)
EUR 875

Recombinant Hydra vulgaris Antistasin
MBS1248250-01mgEColi 0.1mg(E-Coli)
EUR 840

Recombinant Hydra vulgaris Antistasin
MBS1248250-01mgYeast 0.1mg(Yeast)
EUR 1020

Recombinant Hydra vulgaris Endoglycoceramidase
MBS1353485-005mgBaculovirus 0.05mg(Baculovirus)
EUR 1270

Recombinant Hydra vulgaris Endoglycoceramidase
MBS1353485-005mgEColi 0.05mg(E-Coli)
EUR 1070

Recombinant Hydra vulgaris Endoglycoceramidase
MBS1353485-005mgYeast 0.05mg(Yeast)
EUR 1125

Recombinant Hydra vulgaris Endoglycoceramidase
MBS1353485-02mgEColi 0.2mg(E-Coli)
EUR 1390

Recombinant Hydra vulgaris Endoglycoceramidase
MBS1353485-02mgYeast 0.2mg(Yeast)
EUR 1515

Recombinant Hydra vulgaris Periculin-1
MBS1388691-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1065

Recombinant Hydra vulgaris Periculin-1
MBS1388691-002mgEColi 0.02mg(E-Coli)
EUR 650

Recombinant Hydra vulgaris Periculin-1
MBS1388691-002mgYeast 0.02mg(Yeast)
EUR 815

Recombinant Hydra vulgaris Periculin-1
MBS1388691-01mgEColi 0.1mg(E-Coli)
EUR 750

Recombinant Hydra vulgaris Periculin-1
MBS1388691-01mgYeast 0.1mg(Yeast)
EUR 955

Recombinant Hydra viridissima Hydralysin-1 (Hln-1)
MBS1447651-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1125

Recombinant Hydra viridissima Hydralysin-1 (Hln-1)
MBS1447651-002mgEColi 0.02mg(E-Coli)
EUR 755

Recombinant Hydra viridissima Hydralysin-1 (Hln-1)
MBS1447651-002mgYeast 0.02mg(Yeast)
EUR 915

Recombinant Hydra viridissima Hydralysin-1 (Hln-1)
MBS1447651-01mgEColi 0.1mg(E-Coli)
EUR 905

Recombinant Hydra viridissima Hydralysin-1 (Hln-1)
MBS1447651-01mgYeast 0.1mg(Yeast)
EUR 1070

Recombinant Hydra viridissima Hydralysin-2 (Hln-2)
MBS1450847-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1125

Recombinant Hydra viridissima Hydralysin-2 (Hln-2)
MBS1450847-002mgEColi 0.02mg(E-Coli)
EUR 755

Recombinant Hydra viridissima Hydralysin-2 (Hln-2)
MBS1450847-002mgYeast 0.02mg(Yeast)
EUR 915

Recombinant Hydra viridissima Hydralysin-2 (Hln-2)
MBS1450847-01mgEColi 0.1mg(E-Coli)
EUR 905

Recombinant Hydra viridissima Hydralysin-2 (Hln-2)
MBS1450847-01mgYeast 0.1mg(Yeast)
EUR 1070

Recombinant Hydra viridissima Hydralysin-3 (Hln-3)
MBS1383547-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1135

Recombinant Hydra viridissima Hydralysin-3 (Hln-3)
MBS1383547-002mgEColi 0.02mg(E-Coli)
EUR 720

Recombinant Hydra viridissima Hydralysin-3 (Hln-3)
MBS1383547-002mgYeast 0.02mg(Yeast)
EUR 890

Recombinant Hydra viridissima Hydralysin-3 (Hln-3)
MBS1383547-01mgEColi 0.1mg(E-Coli)
EUR 865

Recombinant Hydra viridissima Hydralysin-3 (Hln-3)
MBS1383547-01mgYeast 0.1mg(Yeast)
EUR 1040

Recombinant Hydra vulgaris Morphogenetic neuropeptide
MBS1011399-005mgBaculovirus 0.05mg(Baculovirus)
EUR 875

Recombinant Hydra vulgaris Morphogenetic neuropeptide
MBS1011399-005mgEColi 0.05mg(E-Coli)
EUR 490

Recombinant Hydra vulgaris Morphogenetic neuropeptide
MBS1011399-005mgYeast 0.05mg(Yeast)
EUR 690

Recombinant Hydra vulgaris Morphogenetic neuropeptide
MBS1011399-02mgEColi 0.2mg(E-Coli)
EUR 640

Recombinant Hydra vulgaris Morphogenetic neuropeptide
MBS1011399-05mgEColi 0.5mg(E-Coli)
EUR 695

Hydra-Sponge w/ Peptone Water - PK100
FSA1172 PK100
EUR 244.35

Anti Hydra SP5 mouse monoclonal antibody
MBS157902-01mL 0.1mL
EUR 350

Anti Hydra SP5 mouse monoclonal antibody
MBS157902-5x01mL 5x0.1mL
EUR 1250

Recombinant Hydra vulgaris KS1 protein (KS1)
MBS1066916-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1120

Recombinant Hydra vulgaris KS1 protein (KS1)
MBS1066916-002mgEColi 0.02mg(E-Coli)
EUR 700

Recombinant Hydra vulgaris KS1 protein (KS1)
MBS1066916-002mgYeast 0.02mg(Yeast)
EUR 875

Recombinant Hydra vulgaris KS1 protein (KS1)
MBS1066916-01mgEColi 0.1mg(E-Coli)
EUR 840

Recombinant Hydra vulgaris KS1 protein (KS1)
MBS1066916-01mgYeast 0.1mg(Yeast)
EUR 1020

Recombinant Hydra vulgaris Annexin-B12 (ANXB12)
MBS1096630-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1195

Recombinant Hydra vulgaris Annexin-B12 (ANXB12)
MBS1096630-002mgEColi 0.02mg(E-Coli)
EUR 845

Recombinant Hydra vulgaris Annexin-B12 (ANXB12)
MBS1096630-002mgYeast 0.02mg(Yeast)
EUR 985

Recombinant Hydra vulgaris Annexin-B12 (ANXB12)
MBS1096630-01mgEColi 0.1mg(E-Coli)
EUR 1015

Recombinant Hydra vulgaris Annexin-B12 (ANXB12)
MBS1096630-01mgYeast 0.1mg(Yeast)
EUR 1120

Recombinant Hydra vulgaris Tropomyosin-1 (TROP1)
MBS1144651-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1135

Recombinant Hydra vulgaris Tropomyosin-1 (TROP1)
MBS1144651-002mgEColi 0.02mg(E-Coli)
EUR 765

Recombinant Hydra vulgaris Tropomyosin-1 (TROP1)
MBS1144651-002mgYeast 0.02mg(Yeast)
EUR 925

Recombinant Hydra vulgaris Tropomyosin-1 (TROP1)
MBS1144651-01mgEColi 0.1mg(E-Coli)
EUR 920

Recombinant Hydra vulgaris Tropomyosin-1 (TROP1)
MBS1144651-01mgYeast 0.1mg(Yeast)
EUR 1080

Recombinant Hydra vulgaris Actin, non-muscle 6.2
MBS1128576-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1250

Recombinant Hydra vulgaris Actin, non-muscle 6.2
MBS1128576-002mgEColi 0.02mg(E-Coli)
EUR 915

Recombinant Hydra vulgaris Actin, non-muscle 6.2
MBS1128576-002mgYeast 0.02mg(Yeast)
EUR 1040

Recombinant Hydra vulgaris Actin, non-muscle 6.2
MBS1128576-01mgEColi 0.1mg(E-Coli)
EUR 1100

Recombinant Hydra vulgaris Actin, non-muscle 6.2
MBS1128576-01mgYeast 0.1mg(Yeast)
EUR 1185

Recombinant Hydra vulgaris Laminin subunit beta-1
MBS1355494-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1065

Recombinant Hydra vulgaris Laminin subunit beta-1
MBS1355494-002mgEColi 0.02mg(E-Coli)
EUR 650

Recombinant Hydra vulgaris Laminin subunit beta-1
MBS1355494-002mgYeast 0.02mg(Yeast)
EUR 815

Recombinant Hydra vulgaris Laminin subunit beta-1
MBS1355494-01mgEColi 0.1mg(E-Coli)
EUR 755

Recombinant Hydra vulgaris Laminin subunit beta-1
MBS1355494-01mgYeast 0.1mg(Yeast)
EUR 955

Recombinant Hydra viridissima 40S ribosomal protein SA
MBS1043552-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1175

Recombinant Hydra viridissima 40S ribosomal protein SA
MBS1043552-002mgEColi 0.02mg(E-Coli)
EUR 815

Recombinant Hydra viridissima 40S ribosomal protein SA
MBS1043552-002mgYeast 0.02mg(Yeast)
EUR 960

Recombinant Hydra viridissima 40S ribosomal protein SA
MBS1043552-01mgEColi 0.1mg(E-Coli)
EUR 980

Recombinant Hydra viridissima 40S ribosomal protein SA
MBS1043552-01mgYeast 0.1mg(Yeast)
EUR 1125

Recombinant Hydra vulgaris Elongation factor 1-alpha
MBS1050397-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1335

Recombinant Hydra vulgaris Elongation factor 1-alpha
MBS1050397-002mgEColi 0.02mg(E-Coli)
EUR 1030

Recombinant Hydra vulgaris Elongation factor 1-alpha
MBS1050397-002mgYeast 0.02mg(Yeast)
EUR 1130

Recombinant Hydra vulgaris Elongation factor 1-alpha
MBS1050397-01mgEColi 0.1mg(E-Coli)
EUR 1200

Recombinant Hydra vulgaris Elongation factor 1-alpha
MBS1050397-01mgYeast 0.1mg(Yeast)
EUR 1285

Recombinant Hydra attenuata SP5 protein, N- His Tag
MBS157545-005mg 0.05mg
EUR 320

Recombinant Hydra attenuata SP5 protein, N- His Tag
MBS157545-01mg 0.1mg
EUR 410

Recombinant Hydra attenuata SP5 protein, N- His Tag
MBS157545-5x01mg 5x0.1mg
EUR 1520

Recombinant Hydra viridissima Putative ascorbate peroxidase (APX1)
MBS1299441-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1225

Recombinant Hydra viridissima Putative ascorbate peroxidase (APX1)
MBS1299441-002mgEColi 0.02mg(E-Coli)
EUR 885

Recombinant Hydra viridissima Putative ascorbate peroxidase (APX1)
MBS1299441-002mgYeast 0.02mg(Yeast)
EUR 1015

Recombinant Hydra viridissima Putative ascorbate peroxidase (APX1)
MBS1299441-01mgEColi 0.1mg(E-Coli)
EUR 1065

Recombinant Hydra viridissima Putative ascorbate peroxidase (APX1)
MBS1299441-01mgYeast 0.1mg(Yeast)
EUR 1160

Recombinant Hydra vulgaris Ras-like protein RAS1 (RAS1)
MBS1188614-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1110

Recombinant Hydra vulgaris Ras-like protein RAS1 (RAS1)
MBS1188614-002mgEColi 0.02mg(E-Coli)
EUR 690

Recombinant Hydra vulgaris Ras-like protein RAS1 (RAS1)
MBS1188614-002mgYeast 0.02mg(Yeast)
EUR 865

Recombinant Hydra vulgaris Ras-like protein RAS1 (RAS1)
MBS1188614-01mgEColi 0.1mg(E-Coli)
EUR 830

Recombinant Hydra vulgaris Ras-like protein RAS1 (RAS1)
MBS1188614-01mgYeast 0.1mg(Yeast)
EUR 1010

Recombinant Hydra vulgaris Ras-like protein RAS2 (RAS2)
MBS1150542-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1110

Recombinant Hydra vulgaris Ras-like protein RAS2 (RAS2)
MBS1150542-002mgEColi 0.02mg(E-Coli)
EUR 705

Recombinant Hydra vulgaris Ras-like protein RAS2 (RAS2)
MBS1150542-002mgYeast 0.02mg(Yeast)
EUR 860

Recombinant Hydra vulgaris Ras-like protein RAS2 (RAS2)
MBS1150542-01mgEColi 0.1mg(E-Coli)
EUR 825

Recombinant Hydra vulgaris Ras-like protein RAS2 (RAS2)
MBS1150542-01mgYeast 0.1mg(Yeast)
EUR 1010

Recombinant Hydra vulgaris 60S ribosomal protein L15 (RPL15)
MBS1148433-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1125

Recombinant Hydra vulgaris 60S ribosomal protein L15 (RPL15)
MBS1148433-002mgEColi 0.02mg(E-Coli)
EUR 705

Recombinant Hydra vulgaris 60S ribosomal protein L15 (RPL15)
MBS1148433-002mgYeast 0.02mg(Yeast)
EUR 875

Recombinant Hydra vulgaris 60S ribosomal protein L15 (RPL15)
MBS1148433-01mgEColi 0.1mg(E-Coli)
EUR 845

Recombinant Hydra vulgaris 60S ribosomal protein L15 (RPL15)
MBS1148433-01mgYeast 0.1mg(Yeast)
EUR 1025

Recombinant Hydra vulgaris G2/mitotic-specific cyclin-B
MBS1068728-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1235

Recombinant Hydra vulgaris G2/mitotic-specific cyclin-B
MBS1068728-002mgEColi 0.02mg(E-Coli)
EUR 900

Recombinant Hydra vulgaris G2/mitotic-specific cyclin-B
MBS1068728-002mgYeast 0.02mg(Yeast)
EUR 1025

Recombinant Hydra vulgaris G2/mitotic-specific cyclin-B
MBS1068728-01mgEColi 0.1mg(E-Coli)
EUR 1080

Recombinant Hydra vulgaris G2/mitotic-specific cyclin-B
MBS1068728-01mgYeast 0.1mg(Yeast)
EUR 1170

Recombinant Hydra viridissima G2/mitotic-specific cyclin-A
MBS1123045-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1290

Recombinant Hydra viridissima G2/mitotic-specific cyclin-A
MBS1123045-002mgEColi 0.02mg(E-Coli)
EUR 970

Recombinant Hydra viridissima G2/mitotic-specific cyclin-A
MBS1123045-002mgYeast 0.02mg(Yeast)
EUR 1085

Recombinant Hydra viridissima G2/mitotic-specific cyclin-A
MBS1123045-01mgEColi 0.1mg(E-Coli)
EUR 1130

Recombinant Hydra viridissima G2/mitotic-specific cyclin-A
MBS1123045-01mgYeast 0.1mg(Yeast)
EUR 1230

Recombinant Hydra viridissima G2/mitotic-specific cyclin-B
MBS1261963-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1265

Recombinant Hydra viridissima G2/mitotic-specific cyclin-B
MBS1261963-002mgEColi 0.02mg(E-Coli)
EUR 935

Recombinant Hydra viridissima G2/mitotic-specific cyclin-B
MBS1261963-002mgYeast 0.02mg(Yeast)
EUR 1055

Recombinant Hydra viridissima G2/mitotic-specific cyclin-B
MBS1261963-01mgEColi 0.1mg(E-Coli)
EUR 1125

Recombinant Hydra viridissima G2/mitotic-specific cyclin-B
MBS1261963-01mgYeast 0.1mg(Yeast)
EUR 1200

Recombinant Hydra viridissima Adenylyl cyclase-associated protein (CAP)
MBS1030165-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1345

Recombinant Hydra viridissima Adenylyl cyclase-associated protein (CAP)
MBS1030165-002mgEColi 0.02mg(E-Coli)
EUR 1045

Recombinant Hydra viridissima Adenylyl cyclase-associated protein (CAP)
MBS1030165-002mgYeast 0.02mg(Yeast)
EUR 1140

Recombinant Hydra viridissima Adenylyl cyclase-associated protein (CAP)
MBS1030165-01mgEColi 0.1mg(E-Coli)
EUR 1220

Recombinant Hydra viridissima Adenylyl cyclase-associated protein (CAP)
MBS1030165-01mgYeast 0.1mg(Yeast)
EUR 1300

Recombinant Hydra oligactis Heat shock 70 kDa protein (HSP70)
MBS1203402-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1035

Recombinant Hydra oligactis Heat shock 70 kDa protein (HSP70)
MBS1203402-002mgEColi 0.02mg(E-Coli)
EUR 610

Recombinant Hydra oligactis Heat shock 70 kDa protein (HSP70)
MBS1203402-002mgYeast 0.02mg(Yeast)
EUR 785

Recombinant Hydra oligactis Heat shock 70 kDa protein (HSP70)
MBS1203402-01mgEColi 0.1mg(E-Coli)
EUR 710

Recombinant Hydra oligactis Heat shock 70 kDa protein (HSP70)
MBS1203402-01mgYeast 0.1mg(Yeast)
EUR 920

Recombinant Hydra vulgaris Myosin heavy chain, clone 203, partial
MBS1040747-INQUIRE INQUIRE Ask for price

EB Eraser
TD0006-10mg 10mg Ask for price
Description: EB Eraser

EB Eraser
TD0006-1g 1g Ask for price
Description: EB Eraser

EB Eraser
TD0006-1mg 1mg Ask for price
Description: EB Eraser

EB Eraser
TD0006-50mg 50mg Ask for price
Description: EB Eraser

EB Eraser
TD0006-5mg 5mg Ask for price
Description: EB Eraser

EB Eraser
MBS5786698-INQUIRE INQUIRE Ask for price

EB Eraser
MBS8579847-100Tests 100Tests
EUR 195

EB Eraser
MBS8579847-50Tests 50Tests
EUR 160

EB Eraser
MBS8579847-5x100Tests 5x100Tests
EUR 835

EB Eraser
MBS8579847-5x50Tests 5x50Tests
EUR 665

Recombinant Hydra vulgaris Translationally-controlled tumor protein homolog
MBS1366985-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1105

Recombinant Hydra vulgaris Translationally-controlled tumor protein homolog
MBS1366985-002mgEColi 0.02mg(E-Coli)
EUR 695

Recombinant Hydra vulgaris Translationally-controlled tumor protein homolog
MBS1366985-002mgYeast 0.02mg(Yeast)
EUR 855

Recombinant Hydra vulgaris Translationally-controlled tumor protein homolog
MBS1366985-01mgEColi 0.1mg(E-Coli)
EUR 815

Recombinant Hydra vulgaris Translationally-controlled tumor protein homolog
MBS1366985-01mgYeast 0.1mg(Yeast)
EUR 1005

Recombinant Hydra vulgaris PC3-like endoprotease variant B, partial
MBS1168588-INQUIRE INQUIRE Ask for price

Recombinant Hydra vulgaris Tyrosine-protein kinase STK (STK), partial
MBS1066436-INQUIRE INQUIRE Ask for price

Recombinant Hydra vulgaris PC3-like endoprotease variant A, partial
MBS1238977-INQUIRE INQUIRE Ask for price

Recombinant Hydra vulgaris Tyrosine-protein kinase HTK16 (HTK16), partial
MBS1250981-INQUIRE INQUIRE Ask for price

Recombinant Hydra vulgaris Fibroblast growth factor receptor (FGFR), partial
MBS1335630-005mgBaculovirus 0.05mg(Baculovirus)
EUR 1255

Recombinant Hydra vulgaris Fibroblast growth factor receptor (FGFR), partial
MBS1335630-005mgMammalianCell 0.05mg(Mammalian-Cell)
EUR 1510

Recombinant Hydra vulgaris Fibroblast growth factor receptor (FGFR), partial
MBS1335630-05mgEColi 0.5mg(E-Coli)
EUR 1255

Recombinant Hydra vulgaris Fibroblast growth factor receptor (FGFR), partial
MBS1335630-05mgYeast 0.5mg(Yeast)
EUR 1510

Recombinant Hydra vulgaris Fibroblast growth factor receptor (FGFR), partial
MBS1335630-1mgEColi 1mg(E-Coli)
EUR 1990

Recombinant Hydra vulgaris Putative insulin-like peptide receptor (HTK7), partial
MBS1441399-INQUIRE INQUIRE Ask for price

Recombinant Hydra vulgaris Cyclic AMP-responsive element-binding protein (CREB)
MBS1085322-002mgBaculovirus 0.02mg(Baculovirus)
EUR 1135

Recombinant Hydra vulgaris Cyclic AMP-responsive element-binding protein (CREB)
MBS1085322-002mgEColi 0.02mg(E-Coli)
EUR 720

Recombinant Hydra vulgaris Cyclic AMP-responsive element-binding protein (CREB)
MBS1085322-002mgYeast 0.02mg(Yeast)
EUR 890

The general sensitivity of PrimeDirect, PrimeScript and Sansure assays was 55.1%, 69.6% and 69.6%, respectively. The sensitivity elevated amongst samples with Ct<30: 91.9% (n = 34/37), 89.2% (n = 33/37) and 94.6% (n = 35/37) for PrimeDirect, PrimeScript and Sansure assays, respectively. The specificity was 88%, 100% and 100% for PrimeDirect, PrimeScript and Sansure assays, respectively. Within the current research, we confirmed an excellent sensitivity of extraction-free PCR assays, particularly for top viral masses (Ct<30), besides PrimeDirect that displayed imperfect sensitivity and specificity.

Regardless of a decrease sensitivity for low viral masses, extraction-free reagents can present a worthwhile choice, cheaper, simpler and fewer reagent consuming for SARS-CoV-2 diagnostic, particularly in laboratory with decrease expertise and tools for molecular assays.